Revolution Medicines wins FDA nod to provide early access to cancer therapy
Revolution Medicines, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $163.68
+8.3% in 3d after detection
Post-detection moves
1h
—
1d
+6.0%
3d
+8.3%
7d
+4.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS